Abstract
Acute kidney injury (AKI) has a high incidence in neonates. A variety of perinatal factors may contribute to neonatal AKI, resulting in short- and long-term adverse outcomes, including chronic kidney disease. Early diagnosis and timely treatment can significantly improve the outcomes of these babies. Diagnostic criteria for AKI in adults and children are inapplicable to neonates due to the specific pathophysiological characteristics in newborns. In addition, current diagnosis criteria for neonatal AKI are still inconsistent. These all make it more difficult to diagnose neonatal AKI accurately. New biomarkers for kidney injury, such as neutrophil gelatinase-associated lipocalin, kidney injury molecule-1 and interleukin-18, have been found valuable for early and accurate diagnosis and prognosis of neonatal AKI. However, more studies are required to clarify the influencing factors, diagnostic values and clinical significance of those biomarkers. Key words: Acute kidney injury; Biomarkers; Incidence; Infant, newborn
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
